Express Scripts (ESRX) Tops Q3 Earnings & Revenue Estimates
Zacks Investment Research | Nov 01, 2018 07:25AM ET
Express Scripts Holding Company (NASDAQ:ESRX) posted third-quarter 2018 adjusted earnings of $2.43 per share, which beat the Zacks Consensus Estimate of $2.42. Further, adjusted earnings improved 27.9% year over year.
Revenues of $25.56 billion surpassed the Zacks Consensus Estimate of $24.99 billion and inched up 3.6% year over year. The upside was driven by operational cost improvement backed by focus on technology, digital tools, home delivery and specialty services.
The stock has a Zacks Rank #3 (Hold).
Q3 Patient Claim Volume Details
During the quarter, Express Scripts witnessed year-over-year declines in patient claims.
Adjusted network claims were 260.2 million, up 0.3% year over year. Adjusted home delivery and specialty claims were 74.4 million in the reported quarter, down 11.5% year over year.
As a result, net adjusted claims in the third quarter were 334.6 million, down 2.6% year over year. The decline was primarily caused by the loss of certain public-sector clients.
Express Scripts Holding Company Price and Consensus
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.